Therapies

ASX-listed AFT Pharmaceuticals has expanded its therapeutics range with a new dry eye therapy containing Omega-3. The company has introduced...

A proposed merger between two pharmaceutical companies that compete in the glaucoma treatment markets has been given the green light...

Australian researchers are using genetic testing to identify as many people as possible with inherited retinal disease (IRD), in preparation...

For 40 years laser therapy has been the standard treatment for proliferative diabetic retinopathy (PDR), but now Australian ophthalmologists have...

A US company that has incorporated dark adaptometry into a new wearable headset for age-related macular degeneration (AMD) is on...

Adelaide ophthalmic device manufacturer Nova Eye Medical is developing a next generation iTrack glaucoma surgical system to reduce operating times....

In a historical development for the eye health sector, the Therapeutics Goods Administration (TGA) has approved the country’s first true...

In the final instalment of Insight's five-part dry eye series, optometrist Ms Marilyn Stern reveals how low overheads and no...

In Part 4 of Insight's dry eye series, Melcare Biomedical CEO Anthony Moloney reveals how his company's Australian-made product has...

A biopharmaceutical company that is developing cheaper anti-VEGF treatments for Australia and other markets has launched a global clinical trial...